Tesaro

Acquired

Public · Waltham, United States · Founded 2010 · $121.0M raised

Employees
201–500
Founded
2010
Business Model
B2B
Total Funding
$121.0M
Last Round
$101.0M Series BJun 2011
Rounds
2
Type
Public
Acquisition Date
Dec 2018

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 9 investors for this company. The full record is or through the API.

About

TESARO was an oncology-focused biopharmaceutical company founded in 2010 in Waltham, Massachusetts, dedicated to developing and commercializing novel therapeutics for cancer patients. The company's lead products included Niraparib (Zejula), a PARP inhibitor approved in 2017 for ovarian cancer, and Varubi (rolapitant) for chemotherapy-induced nausea and vomiting. TESARO was acquired by GlaxoSmithKline (GSK) in January 2019 for approximately $5.1 billion, and now operates as GSK's oncology business unit.

Summary

Tesaro is a Biotech company based in Waltham, United States, founded in 2010. It has raised $121.0M in total across 2 rounds, most recently a $101.0M Series B round in Jun 2011. Investors include New Enterprise Associates, GlaxoSmithKline and Kleiner Perkins.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionVenture RoundDec 2018

Sign up to see all 4 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tesaro on Indexed.vc
<a href="https://indexed.vc/companies/tesaro"><img src="https://indexed.vc/api/badge/company/tesaro" alt="Tesaro on Indexed.vc" width="260" height="76" /></a>